News & Events
News & Events
Biotalk Episode 12: A Conversation with Soufiane Aboulhouda of Nucleate
On this episode of Biotalk, Locust Walk's Geoff Meyerson welcomes Soufiane Aboulhouda, Co-Founder and Chairman of the Board of Nucleate, a global non-profit dedicated to empowering future biotech leaders through education and fostering innovation in life sciences...
Biotalk Episode 11: A Conversation with Shehnaaz Suliman of ReCode Therapeutics
On this episode of Biotalk, Locust Walk's Daniel Brog welcomes with Shehnaaz Suliman, M.D., CEO of ReCode Therapeutics, a clinical-stage genetic medicines company using its selective organ targeting lipid nanoparticle platform to power the next wave of mRNA and gene...
Biotalk Episode 10: A Conversation with Errik Anderson of Alloy Therapeutics
On this episode of Biotalk, Locust Walk's Geoff Meyerson welcomes Errik Anderson, CEO and Founder of Alloy Therapeutics, to the podcast. Alloy is a trailblazing drug-discovery company, bringing collaborative platforms and services to the biotech world, making...
Biotalk Episode 9 2023 Q3 Report: Global Trends in Biopharma Transactions
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, delves into our 2023 Q3 Report: Global Trends in Biopharma Transactions Report. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing the current state of global private...
2023 Q3 Report: Global Trends in Biopharma Transactions
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2023 Third Quarter Report applies the latest data to analyze current activities in the life sciences deal landscape.
Biotalk Episode 8: A Conversation with Helen Ho of Blueprint Medicines
On this episode of Biotalk, Locust Walk's Andy Meyerson welcomes Helen Ho, Chief Business Officer of Blueprint Medicines, to the podcast. Blueprint Medicines is a pioneering global precision therapy company committed to crafting life-altering medications for...